Showing results (301-310 of 348) with videos related to

Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remissionA S Freedman, D Neuberg, J G Gribben, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 1999
Autologous bone marrow transplantation after histologic transformation of indolent B cell malignanciesJ W Friedberg, D Neuberg, J G Gribben, et al.
Leukemia|September 5, 2015
SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomideH Jiang, C Acharya, G An, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2006
Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signalingO Tournilhac, D D Santos, L Xu, et al.
Leukemia|May 2, 2008
Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivoM A Shammas, H Koley, R C Bertheau, et al.
Leukemia|November 22, 2017
Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myelomaA Gullà, T Hideshima, G Bianchi, et al.
Leukemia|June 29, 2013
Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKsD Cirstea, T Hideshima, L Santo, et al.
British Journal of Haematology|October 6, 2004
A phase 2 study of two doses of bortezomib in relapsed or refractory myelomaS Jagannath, B Barlogie, J Berenson, et al.
Blood|November 24, 1999
Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphomaA S Freedman, D Neuberg, P Mauch, et al.
Leukemia & Lymphoma|May 26, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myelomaR P Gale, R E Park, R W Dubois, et al.
Pageof 35